12:00 AM
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Niox Mino regulatory update

Aerocrine said the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approved the company's 2008 version of Niox Mino to assess patients with airway inflammation. Aerocrine already markets a 2010 version of Niox Mino in the...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >